131 related articles for article (PubMed ID: 32825359)
21. Interaction of Organic Anion Transporter 3-Mediated Uptake of Steviol Acyl Glucuronide, a Major Metabolite of Rebaudioside A, with Selected Drugs.
Zhou D; Xu Y; Wang Y; Li J; Gui C; Zhang H
J Agric Food Chem; 2020 Feb; 68(6):1579-1587. PubMed ID: 31760750
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
Lee WJ; Lee JL; Chang SE; Lee MW; Kang YK; Choi JH; Moon KC; Koh JK
Br J Dermatol; 2009 Nov; 161(5):1045-51. PubMed ID: 19558553
[TBL] [Abstract][Full Text] [Related]
23. Effect of chronic probenecid therapy on cefazolin serum concentrations.
Spina SP; Dillon EC
Ann Pharmacother; 2003 May; 37(5):621-4. PubMed ID: 12708933
[TBL] [Abstract][Full Text] [Related]
24. Transport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20).
Schnabolk GW; Youngblood GL; Sweet DH
Am J Physiol Renal Physiol; 2006 Aug; 291(2):F314-21. PubMed ID: 16478971
[TBL] [Abstract][Full Text] [Related]
25. Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake.
Niemi M; Pasanen MK; Neuvonen PJ
Pharmacol Rev; 2011 Mar; 63(1):157-81. PubMed ID: 21245207
[TBL] [Abstract][Full Text] [Related]
26. Safety and pharmacokinetics of sorafenib combined with capecitabine in patients with advanced solid tumors: results of a phase 1 trial.
Awada A; Gil T; Whenham N; Van Hamme J; Besse-Hammer T; Brendel E; Delesen H; Joosten MC; Lathia CD; Loembé BA; Piccart-Ghebart M; Hendlisz A
J Clin Pharmacol; 2011 Dec; 51(12):1674-84. PubMed ID: 21209247
[TBL] [Abstract][Full Text] [Related]
27. No Effect of Levothyroxine and Levothyroxine-Induced Subclinical Thyrotoxicosis on the Pharmacokinetics of Sorafenib in Healthy Male Subjects.
Huang F; Ajavon A; Huang E; Lettieri J; Liu R; Peña C; Berse M
Thyroid; 2017 Sep; 27(9):1118-1127. PubMed ID: 28741453
[TBL] [Abstract][Full Text] [Related]
28. Effect of transporter inhibition on the distribution of cefadroxil in rat brain.
Chen X; Loryan I; Payan M; Keep RF; Smith DE; Hammarlund-Udenaes M
Fluids Barriers CNS; 2014; 11(1):25. PubMed ID: 25414790
[TBL] [Abstract][Full Text] [Related]
29. HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma.
Lin SM; Lu SN; Chen PT; Jeng LB; Chen SC; Hu CT; Yang SS; Le Berre MA; Liu X; Mitchell DY; Prins K; Grevel J; Peña CA; Meinhardt G
Hepatol Int; 2017 Mar; 11(2):199-208. PubMed ID: 27909950
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine markedly raises the plasma concentrations of repaglinide.
Kajosaari LI; Niemi M; Neuvonen M; Laitila J; Neuvonen PJ; Backman JT
Clin Pharmacol Ther; 2005 Oct; 78(4):388-99. PubMed ID: 16198658
[TBL] [Abstract][Full Text] [Related]
31. Effect of probenecid on the pharmacokinetics and pharmacodynamics of procainamide.
Lam YW; Boyd RA; Chin SK; Chang D; Giacomini KM
J Clin Pharmacol; 1991 May; 31(5):429-32. PubMed ID: 2050827
[TBL] [Abstract][Full Text] [Related]
32. Effect of probenecid on the pharmacokinetics of carbamazepine in healthy subjects.
Kim KA; Oh SO; Park PW; Park JY
Eur J Clin Pharmacol; 2005 Jun; 61(4):275-80. PubMed ID: 15915352
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects.
Stocker SL; Williams KM; McLachlan AJ; Graham GG; Day RO
Clin Pharmacokinet; 2008; 47(2):111-8. PubMed ID: 18193917
[TBL] [Abstract][Full Text] [Related]
34. Effect of probenecid on the enantioselective pharmacokinetics of oxprenolol and its glucuronides in the rabbit.
Laethem ME; Belpaire FM; Wijnant P; Bogaert MG
Pharm Res; 1995 Dec; 12(12):1964-7. PubMed ID: 8786974
[TBL] [Abstract][Full Text] [Related]
35. Organic anion-transporting polypeptide 1B1 mediates transport of Gimatecan and BNP1350 and can be inhibited by several classic ATP-binding cassette (ABC) B1 and/or ABCG2 inhibitors.
Oostendorp RL; van de Steeg E; van der Kruijssen CM; Beijnen JH; Kenworthy KE; Schinkel AH; Schellens JH
Drug Metab Dispos; 2009 Apr; 37(4):917-23. PubMed ID: 19139163
[TBL] [Abstract][Full Text] [Related]
36. The organic anion transport inhibitor probenecid increases brain concentrations of the NKCC1 inhibitor bumetanide.
Töllner K; Brandt C; Römermann K; Löscher W
Eur J Pharmacol; 2015 Jan; 746():167-73. PubMed ID: 25449033
[TBL] [Abstract][Full Text] [Related]
37. Impact of curcumin on the pharmacokinetics of rosuvastatin in rats and dogs based on the conjugated metabolites.
Zhou X; Zhang F; Chen C; Guo Z; Liu J; Yu J; Xu Y; Zhong D; Jiang H
Xenobiotica; 2017 Mar; 47(3):267-275. PubMed ID: 27174018
[TBL] [Abstract][Full Text] [Related]
38. The Effect of Single and Multiple Doses of Rifampin on the Pharmacokinetics of Doravirine in Healthy Subjects.
Yee KL; Khalilieh SG; Sanchez RI; Liu R; Anderson MS; Manthos H; Judge T; Brejda J; Butterton JR
Clin Drug Investig; 2017 Jul; 37(7):659-667. PubMed ID: 28353169
[TBL] [Abstract][Full Text] [Related]
39. Genetic predisposition of hand-foot skin reaction after sorafenib therapy in patients with hepatocellular carcinoma.
Lee JH; Chung YH; Kim JA; Shim JH; Lee D; Lee HC; Shin ES; Yoon JH; Kim BI; Bae SH; Koh KC; Park NH
Cancer; 2013 Jan; 119(1):136-42. PubMed ID: 22736425
[TBL] [Abstract][Full Text] [Related]
40. Preincubation With Everolimus and Sirolimus Reduces Organic Anion-Transporting Polypeptide (OATP)1B1- and 1B3-Mediated Transport Independently of mTOR Kinase Inhibition: Implication in Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions.
Farasyn T; Crowe A; Hatley O; Neuhoff S; Alam K; Kanyo J; Lam TT; Ding K; Yue W
J Pharm Sci; 2019 Oct; 108(10):3443-3456. PubMed ID: 31047942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
